Steven Leichter is an Endocrinology/Metabolic physician affiliated with Mercer University. OpenAlex indexes 62 publications with 1,225 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2425 Brookstone Centre Pkwy
Columbus, GA 319044501
Telephone
706-322-1700Registry record last updated 8 Jul 2007.
Clinical trials
- Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Sponsor: Columbus Research Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
52 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202510 payments
- SANOFI-AVENTIS U.S. LLCProgram year202513 payments
- Amgen Inc.Program year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
87.5%Androgen87.3%Testosterone cypionate100%Testosterone Cypionate0%Testosterone0%Part D + Part B<11 patientsEstrogen0.2%Estradiol66%Estradiol (Once Weekly)34%Part D<11 patientsMetabolism & gastrointestinal
6%Insulin Analog1.4%Tresiba Flextouch U-10019%Lantus Solostar18%Novolog Flexpen14%Insulin Lispro Kwikpen U-1009%Humalog Kwikpen U-1007%Novolog7%Basaglar Kwikpen U-1006%Humalog5%Insulin Lispro3%Fiasp Flextouch3%Insulin Aspart Flexpen3%Toujeo Solostar2%Lyumjev Kwikpen U-1002%Toujeo Max Solostar2%Part D<11 patientsBiguanide (metformin)1.1%Metformin Hcl60%Metformin Hcl Er40%Part D≥122 patients+ 13 more classes in this area
Cardiovascular
4.1%Statin1.5%Atorvastatin Calcium52%Pravastatin Sodium33%Rosuvastatin Calcium12%Simvastatin4%Part D≥140 patientsCalcium channel blocker0.6%Amlodipine Besylate75%Diltiazem 24hr Er (Cd)19%Amlodipine Besylate-Benazepril6%Part D<11 patients+ 14 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers
The Journal of Clinical Endocrinology & Metabolism
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lauterbach, MD
Mercer University
Christopher Arant, MD
Mercer University
Harold Katner, MD
Mercer University
David Adamson, MD, PhD, MPH
Mercer University
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”